Align Technology announced it will add three new independent directors to its board and launch a review of its operations, following talks with activist investor Elliott Investment Management.
Changes and Review
The medical device company, best known for making Invisalign clear teeth aligners, said it raised its share buyback target for the year to between $400 million and $500 million, up from the earlier target of $200 million, citing confidence in its long-term value.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
